27 Mar 2023 | Discover home page, Discover ImPact
Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer Pancreatic cancer, non-viral gene therapy, resistance to treatment, chemotherapy, preclinical regulatory experiments. Pierre Cordelier Team ImPact- Therapeutic innovation in...
15 Mar 2023 | Discover home page, Discover IGAALD
Acquired genetic abnormalities predict outcome in patients with GATA2 deficiency GATA2, leukemic transformation, clonal hematopoiesis, STAG2, genotype-phenotype correlation, Laétitia Largeaud team IGGALD- Impact of genetic alterations on acute leukemia development...
20 Feb 2023 | Discover home page
The CRCT presents its Top 5 publications from its teams in 2022. Find all the 2022 publications of each team on their dedicated page. Ultrarapid Lytic Granule Release from CTLs Activates Ca2+-Dependent Synaptic Resistance Pathways in Melanoma Cells Filali, Liza,...
17 Feb 2023 | Discover home page, Discover Micropanc
Single-cell spatial explorer a software to to analyse the cells characteristics in relation with their position in any kind of biological tissue Freeware, Multimodal analysis, Open-source, Single-cell, Spatial transcriptomics, Visualization, Frédéric Pont,...
17 Feb 2023 | Discover home page, Discover SigDyn
How to target PI3Ks 3 classes in cancer? PI3K, cell signaling, Combi/hydrides-molecules, combination therapeutics, Cancer, Benoît Thibault, équipe SigDyn – Signalisation cellulaire intégrée et isoformes de PI3K PI3Ks are a family of 3 classes of enzymes that are...
3 Feb 2023 | Discover home page, scholar_en
#CRCTSCHOLARThe CRCT conferences Lessons from the melanoma ecosystem Conference of Dr Florian Rambow, IKIM Institute, GermanyVideoconference Teams given on Friday, February 03, within the framework of the CRCT Scientific Animation Committee. Primary resistance...
